Veterinary Product Information
AmTech Levothyroxine Sodium Tablets
This page contains information on AmTech Levothyroxine Sodium Tablets for veterinary use.The information provided typically includes the following:
- AmTech Levothyroxine Sodium Tablets Indications
- Warnings and cautions for AmTech Levothyroxine Sodium Tablets
- Direction and dosage information for AmTech Levothyroxine Sodium Tablets
Amtech Levothyroxine Sodium Tablets
This treatment applies to the following species:Description
Each Levothyroxine Sodium Tablet provides synthetic crystalline levothyroxine sodium (L-Thyroxine).
Action
Levothyroxine sodium acts as does endogenous thyroxine, to stimulate metabolism, growth, development and differentiation on tissues. It increases the rate of energy exchange and increases the maturation rate of the epiphyses. Levothyroxine sodium is absorbed rapidly from the gastrointestinal tract after oral administration. Following absorption, the compound becomes bound to the serum alpha globulin fraction. For purposes of comparison 0.1 mg. of levothyroxine sodium elicits a clinical response approximately equal to that produced by one grain (65 mg.) of desiccated thyroid.
AmTech Levothyroxine Sodium Tablets Indications
Provides thyroid replacement therapy in all conditions of inadequate production of thyroid hormones. Hypothyroidism is the generalized metabolic disease resulting from deficiency of the thyroid hormones levothyroxine (T4) and liothyronine (T3). Levothyroxine sodium will provide levothyroxine (T4) as a substrate for the physiologic deiodination to liothyronine (T3). Administration of levothyroxine sodium alone will result in complete physiologic thyroid replacement.
Canine hypothyroidism is usually primary, ie., due to atrophy of the thyroid gland. In the majority of cases the atrophy is associated with lymphocytic thyroiditis and in the remainder it is non-inflammatory and as of yet unknown etiology. Less than 10 percent of cases of hypothyroidism are secondary, i.e., due to deficiency of thyroid stimulating hormone (TSH). TSH deficiency may occur as a component of congenital hypopituitarism or as an acquired disorder in adult dogs, in which case it is invariably due to the growth of a pituitary tumor.
Hypothyroidism In The Dog
Hypothyroidism usually occurs in middle-aged and older dogs although the condition will sometimes be seen in younger dogs of the larger breeds. Neutered animals of either sex are also frequently affected, regardless of age. The following are clinical signs of hypothyroidism in dogs:
Lethargy, lack of endurance, increased sleeping
Reduced interest, alertness and excitability
Slow heart rate, weak apex beat and pulse, low voltage on ECG
Preference for warmth, low body temperature, cool skin
Increased body weight
Stiff and slow movements, dragging of front feet
Head tilt, disturbed balance, unilateral facial paralysis
Atrophy of epidermis, thickening of dermis
Surface and follicular hyperkeratosis, pigmentation
Puffy face, blepharoptosis, tragic expression
Dry, coarse, sparse coat, slow regrowth after clipping
Retarded turnover of hair (carpet coat of boxers)
Shortening or absence of estrus, lack of libido
Dry feces, occasional diarrhea
Hypercholesterolemia
Normochromic, normocytic anemia
Elevated serum creatinine phosphokinase
Contraindications
Levothyroxine sodium therapy is contraindicated in thyrotoxicosis, acute myocardial infraction and uncorrected adrenal insufficiency. Use in pregnant bitches has not been evaluated.
Precautions
The effects of levothyroxine sodium therapy are slow in being manifested. Overdosage of any thyroid drug may produce the signs and symptoms of thyrotoxicosis including but not limited to polydipsia, polyuria, polyphagia, reduced heat tolerance and hyperactivity or personality change. Administer with caution to animals with clinically significant heart disease, hypertension or other complications for which a sharply increased metabolic rate might prove hazardous.
Adverse Reactions
There are no particular adverse reactions connected with L-Thyroxine therapy at the recommended dosage levels. Overdose will result in the signs of thyrotoxicosis listed above under precautions.
Dosage
The initial recommended daily dose is 0.1 mg/10 lb body weight. Dosage is then adjusted according to patient's response by monitoring T4 blood levels at time intervals of four weeks.
Administration
Thyroxine tablets may be administered orally or placed in the food.
Dosage Forms Available
0.2 mg - pink
0.5 mg - white
0.8 mg - light blue
Tablets in bottles of 180 and 1000.
AmTech Levothyroxine Sodium Tablets Caution
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Storage
Store Between 15°c And 30°c (59°f And 86°f).
Tightly close this container after each use.
For Animal Use Only
Keep Out Of Reach Of Children
AmTech® is a registered trademark of IVX Animal Health, Inc.
Manufactured by IVX Animal Health, Inc., St. Joseph, MO 64503
Rev1105
|
|
Net Contents: |
NDC |
|
|
0.2 mg |
180 TABLETS |
59130-695-25 |
801008-25 Rev. 5-01 |
|
0.2 mg |
1000 TABLETS |
59130-695-26 |
801008-26 Rev1206 |
|
0.5 mg |
180 TABLETS |
59130-698-25 |
801011-25 Rev. 5-01 |
|
0.5 mg |
1000 TABLETS |
59130-698-26 |
801011-26 Rev. 5-01 |
|
0.8 mg |
180 TABLETS |
59130-701-25 |
801014-25 Rev. 5-01 |
|
0.8 mg |
1000 TABLETS |
59130-701-26 |
801014-26 Rev0107 |
Nac No.
10740274formerly known as Phoenix Scientific, Inc.
3915 S. 48TH ST. TERRACE, P.O. BOX 8039 (64508), ST. JOSEPH, MO, 64503
| Telephone: | 800-759-3664 | |
| Fax: | 816-676-6878 | |
| Website: | www.psiqv.com | |
| Website: | www.ivxanimalhealth.com |
![]() |
Every effort has been made to ensure the accuracy of the AmTech Levothyroxine Sodium Tablets information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the AmTech Levothyroxine Sodium Tablets product label or package insert. |
![]() |
Printable Version | ![]() |
Email Page |








